Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerK Ribi, J Aldridge, K-A Phillips, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03G D'Addario, D Rauch, R Stupp, et al.
Nature Communications|May 7, 2026
Glycosite mapping and in situ mass spectrometry imaging of MUC2 glycopeptides via on-slide mucinase digestionSarah C Lowery, Mikaela K Ribi, Joann Chongsaritsinsuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)D Koeberle, J-F Dufour, G Demeter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99O Pagani, D Klingbiel, T Ruhstaller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 12, 2017
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trialA Gennari, Z Sun, U Hasler-Strub, et al.
Breast (Edinburgh, Scotland)|July 31, 2019
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European CentersM Ruggeri, E Pagan, V Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trialE Felip, S Popat, U Dafni, et al.
Nature Biotechnology|December 16, 2025
Antibody-lectin chimeras for glyco-immune checkpoint blockadeJessica C Stark, Melissa A Gray, Itziar Ibarlucea-Benitez, et al.
European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.
Pageof 3